These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12209049)

  • 41. Proceedings of the XIIth International Symposium on Advances in Targeted Therapies. April 14-18, 2010.
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i1-122. PubMed ID: 21438187
    [No Abstract]   [Full Text] [Related]  

  • 42. Neurological complications of infliximab.
    Tektonidou MG
    J Rheumatol; 2007 Jan; 34(1):237; author reply 237-8. PubMed ID: 17216701
    [No Abstract]   [Full Text] [Related]  

  • 43. [News in rheumatology. The Danish Society of Rheumatology].
    Østergaard M; Steengaard-Pedersen K; Herlin T; Kjaer M; Døhn UM; Nørregaard J; Madsen OR;
    Ugeskr Laeger; 2007 Mar; 169(12):1131. PubMed ID: 17394842
    [No Abstract]   [Full Text] [Related]  

  • 44. Anti-tumour necrosis factor agents and lipid profile: a class effect?
    Garcês SP; Parreira Santos MJ; Vinagre FM; Roque RM; da Silva JA
    Ann Rheum Dis; 2008 Jun; 67(6):895-6. PubMed ID: 18474660
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.
    Gibofsky A
    J Hypertens Suppl; 2002 Sep; 20(6):S25-30. PubMed ID: 12683424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Career lifetime advances in rheumatology.
    Scott DL
    Clin Med (Lond); 2010 Apr; 10(2):156-9. PubMed ID: 20437989
    [No Abstract]   [Full Text] [Related]  

  • 47. Prospects for disease modification in ankylosing spondylitis: do nonsteroidal antiinflammatory drugs do more than treat symptoms?
    Ward MM
    Arthritis Rheum; 2005 Jun; 52(6):1634-6. PubMed ID: 15934065
    [No Abstract]   [Full Text] [Related]  

  • 48. [TNF-alpha antagonists in therapy of rheumatoid arthritis].
    Gross WL; Gause A
    Z Rheumatol; 2003 Jun; 62(3):217. PubMed ID: 12931691
    [No Abstract]   [Full Text] [Related]  

  • 49. [The use of methotrexate in rheumatology: results and prospects].
    Nasonov EL
    Klin Med (Mosk); 1996; 74(5):10-5. PubMed ID: 8999172
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pain therapy in rheumatism. After 65 years of age coxibs are the best choice].
    MMW Fortschr Med; 2003 Oct; 145(42):60. PubMed ID: 14655447
    [No Abstract]   [Full Text] [Related]  

  • 51. Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care.
    Pincus T; Braun J; Kavanaugh A; Smolen JS
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-1. PubMed ID: 25365080
    [No Abstract]   [Full Text] [Related]  

  • 52. Rheumatology.
    Bradlow A; David J
    BMJ; 1995 Mar; 310(6980):637-40. PubMed ID: 7703753
    [No Abstract]   [Full Text] [Related]  

  • 53. The use of infliximab in academic rheumatology practice: an audit of early clinical experience.
    Fitzcharles MA; Clayton D; Ménard HA
    J Rheumatol; 2002 Dec; 29(12):2525-30. PubMed ID: 12465146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antimalarial preparations in rheumatology: new prospects].
    Nasonov EL
    Ter Arkh; 1996; 68(1):67-71. PubMed ID: 8644039
    [No Abstract]   [Full Text] [Related]  

  • 55. [Intra-articular infiltrations in rheumatology: update].
    Chevalier-Ruggeri P; Zufferey P
    Rev Med Suisse; 2016 Jan; 12(500):90-4. PubMed ID: 26946713
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Indications and adverse events with the use of anti-TNFalpha agents in pediatric rheumatology: experience of a single center].
    de Oliveira SK; de Almeida RG; Fonseca AR; Rodrigues MC; Sztajnbok F; Diniz C
    Acta Reumatol Port; 2007; 32(2):139-50. PubMed ID: 17572652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Robin goodfellow.
    Rheumatology (Oxford); 2001 Oct; 40(10):1198. PubMed ID: 11600758
    [No Abstract]   [Full Text] [Related]  

  • 58. 'Life cycle in modern rheumatology' matters: new drugs require new therapeutic strategies and innovative diagnostics.
    Dörner T; Burmester GR
    Curr Opin Rheumatol; 2008 May; 20(3):237-8. PubMed ID: 18388511
    [No Abstract]   [Full Text] [Related]  

  • 59. Rheumatology in and from Slovenia.
    Adebajo A; Espinoza LR
    Clin Rheumatol; 2019 Feb; 38(2):271. PubMed ID: 30288623
    [No Abstract]   [Full Text] [Related]  

  • 60. COVID-19 and rheumatology: Reflecting on the first wave and preparing for the second wave.
    Fardanesh A; Byravan S; Moorthy A; Tahir H
    Int J Rheum Dis; 2021 Jan; 24(1):7-9. PubMed ID: 33459529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.